The pharmaceutical sector is currently at a strategic crossroads, marked by significant technological advancements and complex regulatory challenges. The integration of Artificial Intelligence (AI) and Big Data continues to transform the landscape, with major initiatives like Google's and Meta's "virtual cell," promising to revolutionize biomedical research. However, this technological dynamic is accompanied by increased risks, notably in data security and regulatory compliance, which are particularly critical for SMEs in the sector.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
